Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1978-2-23
|
pubmed:abstractText |
Oral sustained release cephalexin (S-6437) was administered to 24 pediatric patients. Daily dose used was 18 approximately 60 mg/kg, which was divided into two doses and given after breakfast and dinner. The following are the results of the study. Out of 24 patients, 6 showed very good response, 10 good response, 6 fair, 1 poor and 1 unknown, Ratio of effectiveness was 69.6%. Two patients were reluctant to receive the drug and, therefore, they took other drugs. The other 22 patients, however, were easily given. No remarkable side effects due to S-6437 were found. From the above results, it was recognized that S-6437 has good effectiveness and safety, and it is convenient to give to children because the frequency of the drug administration is only twice a day.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0368-2781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
888-92
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:592489-Administration, Oral,
pubmed-meshheading:592489-Age Factors,
pubmed-meshheading:592489-Bacterial Infections,
pubmed-meshheading:592489-Cephalexin,
pubmed-meshheading:592489-Child,
pubmed-meshheading:592489-Child, Preschool,
pubmed-meshheading:592489-Delayed-Action Preparations,
pubmed-meshheading:592489-Drug Evaluation,
pubmed-meshheading:592489-Female,
pubmed-meshheading:592489-Humans,
pubmed-meshheading:592489-Infant,
pubmed-meshheading:592489-Male
|
pubmed:year |
1977
|
pubmed:articleTitle |
[Clinical experience with sustained release cephalexin (X-6437) (author's transl)].
|
pubmed:publicationType |
Journal Article,
English Abstract
|